Ameditech Inc recalls DrugSmart Dip (MET/OPI2)+AMP+BZO+COC+THC, Item No. 30600D; DrugSmart Dip AMP/OPI2/COC/THC/BZO Test, Item No. 30520D Th

Recalled November 25, 2015 · FDA recall Z-0309-2016 · Ameditech

Hazard

Ameditech is recalling drug abuse tests because they have shown reduced reactivity. · FDA Class II

Units

160 units

Sold at

Worldwide Distribution - US (nationwide) and Internationally to Australia.

Description

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Product

DrugSmart Dip (MET/OPI2)+AMP+BZO+COC+THC, Item No. 30600D; DrugSmart Dip AMP/OPI2/COC/THC/BZO Test, Item No. 30520D These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Manufacturer(s)

Ameditech Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →